Literature DB >> 17454963

The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.

F Tanriverdi1, Z Karaca, K Unluhizarci, F Kelestimur.   

Abstract

The hypothalamo-pituitary-adrenal (HPA) axis plays a major role in the regulation of responses to stress. Human stress-related disorders such as chronic fatigue syndrome (CFS), fibromyalgia syndrome (FMS), chronic pelvic pain and post-traumatic stress disorder are characterized by alterations in HPA axis activity. However, the role of the HPA axis alterations in these stress-related disorders is not clear. Most studies have shown that the HPA axis is underactive in the stress-related disorders, but contradictory results have also been reported, which may be due to the patients selected for the study, the methods used for the investigation of the HPA axis, the stage of the syndrome when the tests have been done and the interpretation of the results. There is no structural abnormality in the endocrine organs which comprise the HPA axis, thus it seems that hypocortisolemia found in the patients with stress-related disorder is functional. It may be also an adaptive response of the body to chronic stress. In this review, tests used in the assessment of HPA axis function and the HPA axis alterations found in CFS and FMS are discussed in detail.

Entities:  

Mesh:

Year:  2007        PMID: 17454963     DOI: 10.1080/10253890601130823

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  30 in total

1.  Shortness of filum terminale represents an anatomical specific feature in fibromyalgia: a nuclear magnetic resonance and clinical study.

Authors:  Roberto Mantia; Marco Di Gesù; Angelo Vetro; Fabrizio Mantia; Sebastiano Palma; Angelo Iovane
Journal:  Muscles Ligaments Tendons J       Date:  2015-03-27

Review 2.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

3.  Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management.

Authors:  Firdous Jahan; Kashmira Nanji; Waris Qidwai; Rizwan Qasim
Journal:  Oman Med J       Date:  2012-05

4.  Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers.

Authors:  Gulsah Elbuken; Fatih Tanriverdi; Zuleyha Karaca; Mustafa Kula; Selma Gokahmetoglu; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2014-08-13       Impact factor: 3.633

5.  Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study.

Authors:  Kirstin Aschbacher; Emma K Adam; Leslie J Crofford; Margaret E Kemeny; Mark A Demitrack; Amos Ben-Zvi
Journal:  Brain Behav Immun       Date:  2012-06-09       Impact factor: 7.217

6.  Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).

Authors:  Osamu Hotta; Ayaki Tanaka; Akira Torigoe; Kazuaki Imai; Norio Ieiri
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Inspiratory airflow dynamics during sleep in veterans with Gulf War illness: a controlled study.

Authors:  Mohammad M Amin; Zuzana Belisova; Sayeed Hossain; Morris S Gold; Joan E Broderick; Avram R Gold
Journal:  Sleep Breath       Date:  2010-08-12       Impact factor: 2.816

8.  Identification of a potential molecular link between the glucocorticoid and serotonergic signaling systems.

Authors:  Virginia R Falkenberg; Mangalathu S Rajeevan
Journal:  J Mol Neurosci       Date:  2010-01-06       Impact factor: 3.444

9.  Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder.

Authors:  Elling Ulvestad
Journal:  Med Health Care Philos       Date:  2008-02-21

10.  Traditional chinese medicine for chronic fatigue syndrome.

Authors:  Rui Chen; Junji Moriya; Jun-Ichi Yamakawa; Takashi Takahashi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.